Global Gene Expression Regulation Mediated by TGFβ Through H3K9me3 Mark

Area of Science:

• Epigenetics
• Cancer Biology
• Molecular Oncology

Background:

• Epigenetic alterations are crucial in cancer development, affecting key cellular processes.
• Transforming growth factor beta (TGFβ) signaling is a known regulator of tumorigenesis.
• The interplay between TGFβ signaling and epigenetic modifications, specifically H3K9me3, in cancer is not well understood.

Purpose of the Study:

• To investigate the genome-wide effects of TGFβ signaling on the H3K9me3 epigenetic landscape in prostate cancer.
• To explore the functional consequences of TGFβ-induced H3K9me3 alterations in tumorigenesis.

Main Methods:

• Chromatin-Immunoprecipitation followed by sequencing (ChIP-seq) to map H3K9me3 occupancy genome-wide.
• Bioinformatic analysis using DAVID and MEME-ChIP tools for functional annotation and motif discovery.

Main Results:

• TGFβ stimulation led to increased H3K9me3 occupancy in intronic regions (6 hours) and distal intergenic regions (24 hours).
• A potential association between SLC transporters and H3K9me3 was observed in the presence of TGFβ.
• No direct correlation was found between H3K9me3 occupancy and gene expression, but regulation was linked to SRY and FOXJ3 binding sites.

Conclusions:

• TGFβ signaling positively associates with the oncogenic function of H3K9me3, particularly in cell migration and adhesion.
• TGFβ-mediated H3K9me3 regulation appears to involve transcriptional activation, contrasting with its typical repressive role.